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amide 15 N longitudinal relaxation rate constants were determined from a series of 2D 15 N-13 CO correlation spectra recorded using the pulse scheme described in detail in our earlier study (Nadaud et al., 2010) , with relaxation delays ranging from 100 μs to 4 s. Each spectrum in the relaxation series was collected as a 128* (t1, 15 N) ä 1500* (t2, 13 C) data matrix with time increments of 200 μs and 20 μs, corresponding to acquisition times of 25.6 ms and 30 ms in t1 and t2, respectively. With recycle delays of 0.48 s and 1.2 s for the 28TETAC-Cu 2+ and Zn 2+ samples, respectively, the minimum amount of time required to record a complete relaxation trajectory was ~10 h and ~14.5 h, respectively, for the two samples. For increased signal-to-noise ratio, the measurements were repeated seven and four times, respectively, for the 28TETAC-Cu 2+ and Zn 2+ samples resulting in a total experiment time of ~128 h. All NMR spectra were processed using NMRPipe (Delaglio et al., 1995) and analyzed with Sparky (Goddard and Kneller, 2006) and nmrglue (Helmus and Jaroniec, 2013) .
Fig. S1
. Small regions of 800 MHz 2D 15 N-1 H HSQC solution-state NMR spectra for samples containing 1 mM of (left) 15 N-labeled GB1-K28C, (middle) GB1-K28C modified with an unactivated form of the TETAC tag containing a free thiol group (Lewin et al., 2002) (compound (3) in Scheme S1 below), and (right) GB1-K28C modified with the thiopyridine-activated TETAC tag (compound (4) in Scheme S1). For the middle spectrum resonances indicative of unreacted protein, corresponding to residues located in the vicinity of the C28 tag attachment site, are labeled with asterisks.
Fig. S2
. Experimental (solid) and simulated (dashed) X-band CW ESR spectra of 500 μM 28TETAC-Cu 2+ in 50 mM MES buffer pH 6.8 at 80 K. The fit parameters, A 7 = 191 G, g 7 = 2.162, A^ = 20 G and g^ = 2.026, are consistent with four nitrogen atoms directly coordinating the Cu 2+ ion as expected (Peisach and Blumberg, 1974) .
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Scheme S1. Synthesis of 1-(2-(pyridin-2-yldisulfanyl)ethyl)-1,4,7,10-tetraazacyclododecane (TETAC). (Notni et al., 2009) . To a solution of triphenylmethylbromide (4.79 g, 14.8 mmol; Alfa Aesar, Ward Hill, MA) in dichloromethane (40 mL), excess ethylene sulfide (1.8 mL, 30 mmol; Alfa Aesar) was added at room temperature. After 24 h, the solvent was evaporated resulting in an off-white precipitate. The crude product was redissolved in 30 mL dichloromethane, and upon addition of 50 mL ethanol a precipitate formed immediately. The solution was left undisturbed for 1 h to complete crystallization. The crystals were filtered off, washed with ethanol and dried under vacuum. The reaction yield was 75%. 1 H NMR (600 MHz, CDCl3): 7.59 (d, J=7.86, 3H), 7.44 (t, J=7.67, 3H), 7.37 (t, J=7.30, 2H), 3.03 (t, J=7.95, 2H), 2.88 (t, J=7.03, 2H) ppm; 13 C NMR (150 MHz, CDCl3): 144. 65, 129.68, 128.22, 127.07, 67.64, 34.35, and 30.16 ppm.
2-bromoethyl trityl sulfide (1)
2-(1,4,7,10-tetraazacyclododecan-1-yl)-ethanetritylthiol (2) (Lacerda et al., 2007) . To a solution of excess cyclen (500.2 mg, 2.9 mmol; AK Scientific, Union City, CA) in 50 mL of hot toluene, 2bromoethyl trityl sulfide (1) (279 mg, 0.72 mmol) dissolved in 50 mL of toluene was added dropwise over a period of 2 h. The mixture was refluxed overnight, and subsequently the pH adjusted to 11 using 4 M NaOH. The organic phase was separated and dried under vacuum. The crude product was purified by reversed-phase HPLC on a preparative PROTO-300 C18 10 μm column with a linear H2O:CH3CN gradient (20:80 to 100:0) containing 0.1% TFA (v/v). The 2-(1,4,7,10-tetraazacyclododecan-1-yl)ethanetritylthiol (2) was lyophilized and confirmed by analytical reversed-phase HPLC. The yield was 225 mg (65%). 1 H NMR (600 MHz, CDCl3): 7.47 (d, J=7.68, 6H), 7.33 (t, J=7.64, 6H), 7.25 (t, J=7.37, 3H), 2.84 (m, 4H), 2.68 (m, 9H), 2.50-2.41 (m, 7H) ppm; 13 C NMR (150 MHz, CDCl3): 144. 93, 129.61, 127.84, 126.64, 66.79, 53.94, 51.03, 47.66, 46.09, 45.80, 29 .62 ppm. ESI-MS calculated for C29H38N4S [M+H] + 475.7117, found 475.2662. (Lacerda et al., 2007) . The 225 mg of 2-(1,4,7,10-tetraazacyclododecan-1-yl)-ethanetritylthiol (2) from the previous step was refluxed in 50 mL of 20% HCl for 2 h. After cooling to room temperature, the solution was washed with 3 x 30 mL dichloromethane and the aqueous layer separated and dried under vacuum to give a yellowish product. The yield of 2-(1,4,7,10-tetraazacyclododecan-1-yl)-ethanethiol was 130 mg (96%). ESI-MS calculated for C10H24N4S [M+H] + 233.3973, found 233.1641.
2-(1,4,7,10-tetraazacyclododecan-1-yl)-ethanethiol (3)
1-(2-(pyridin-2-yldisulfanyl)ethyl)-1,4,7,10-tetraazacyclododecane (4). To a solution of 2-(1,4,7,10tetraazacyclododecan-1-yl)ethanethiol (3) (130 mg, 0.560 mol) in 0.5 mL water, methanol was added to a final volume of 25 mL. This solution was added over a period of 1 h to a solution of excess 2,2'dipyridyl disulfide (544 mg, 2.47 mol; AK Scientific) in 25 mL methanol. The reaction was stirred for 36 h under N2 and concentrated at 32 o C by using a rotary evaporator. The resulting yellowish oil was washed with 25 mL of diethyl ether, followed by dissolution in 10 mL water and further washing with diethyl ether (4 x 25 mL). The final aqueous solution was lyophilized to obtain the crude product, which was purified by reversed-phase HPLC on a preparative PROTO-300 C18 10 μm column with a linear H2O:CH3CN gradient (90:10 to 0:100) containing 0.1% TFA (v/v) to give 106 mg of the final 1-(2-(pyridin-2-yldisulfanyl)ethyl)-1,4,7,10-tetraazacyclododecane product as an off-white powder in 55% yield. 1 16, 145.96, 142.49, 125.64, 124.25, 50.83, 47.31, 44.09, 41.95, 41.45, 33 .48 ppm (the quartets centered at 162.72 and 116.25 ppm are due to residual TFA from HPLC purification). ESI-MS calculated for C10H24N4S [M+H] + 342.5384, found 342.1530. S11 Fig. S3 . 1 H NMR spectrum of 2-bromoethyl trityl sulfide (1). S12 Fig. S4 . 13 C NMR spectrum of 2-bromoethyl trityl sulfide (1). S13 Fig. S5 . 1 H NMR spectrum of 2-(1,4,7,10-tetraazacyclododecan-1-yl)-ethanetritylthiol (2). S14 
